4.7 Article

LncRNA-MAP3K4 regulates vascular inflammation through the p38 MAPK signaling pathway and cis-modulation of MAP3K4

Journal

FASEB JOURNAL
Volume 35, Issue 1, Pages -

Publisher

WILEY
DOI: 10.1096/fj.202001654RR

Keywords

bidirectional promoter; vascular cells; ChIP‐ seq; atherosclerosis; eRNA

Funding

  1. American Heart Association (AHA) [20SFRN35200163]
  2. National Institutes of Health (NIH) [HL115141, HL134849, HL148207, HL148355, HL153356]

Ask authors/readers for more resources

Chronic vascular inflammation in atherosclerosis is influenced by a novel long non-coding RNA, lncRNA-MAP3K4, which regulates inflammation through the p38 MAPK signaling pathway. The expression of lncRNA-MAP3K4 is modulated during chronic and acute inflammatory conditions, and knockdown of this lncRNA can reduce inflammatory factor expression in various vascular cells. Cooperation between lncRNA-MAP3K4 and MAP3K4 in reducing inflammation in endothelial cells has also been demonstrated.
Chronic vascular inflammation plays a key role in the pathogenesis of atherosclerosis. Long non-coding RNAs (lncRNAs) have emerged as essential inflammation regulators. We identify a novel lncRNA termed lncRNA-MAP3K4 that is enriched in the vessel wall and regulates vascular inflammation. In the aortic intima, lncRNA-MAP3K4 expression was reduced by 50% during the progression of atherosclerosis (chronic inflammation) and 70% during endotoxemia (acute inflammation). lncRNA-MAP3K4 knockdown reduced the expression of key inflammatory factors (eg, ICAM-1, E-selectin, MCP-1) in endothelial cells or vascular smooth muscle cells and decreased monocytes adhesion to endothelium, as well as reducing TNF-alpha, IL-1 beta, COX2 expression in macrophages. Mechanistically, lncRNA-MAP3K4 regulates inflammation through the p38 MAPK signaling pathway. lncRNA-MAP3K4 shares a bidirectional promoter with MAP3K4, an upstream regulator of the MAPK signaling pathway, and regulates its transcription in cis. lncRNA-MAP3K4 and MAP3K4 show coordinated expression in response to inflammation in vivo and in vitro. Similar to lncRNA-MAP3K4, MAP3K4 knockdown reduced the expression of inflammatory factors in several different vascular cells. Furthermore, lncRNA-MAP3K4 and MAP3K4 knockdown showed cooperativity in reducing inflammation in endothelial cells. Collectively, these findings unveil the role of a novel lncRNA in vascular inflammation by cis-regulating MAP3K4 via a p38 MAPK pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available